# Anabiosi-Data

> AI-driven precision medicine company building digital twins, biomarker discovery, multi-omics analytics, and personalized cancer therapy decision-support tools.

Anabiosi-Data develops software, mathematical models, and AI pipelines for healthcare and biotech: patient-specific digital twins, biomarker analytics, metabolomics/lipidomics pipelines, smart omics + imaging analytics, and in-vivo experimental workflows. Flagship products include Prognostic and LabFlow.

## Pages

- [Home](/): Company overview and ecosystem of AI-driven precision medicine offerings.
- [Services](/services): Full catalog of AI, biomarker, omics, modeling, and preclinical services.
- [Data & Biomarker Analysis](/services/data-biomarker-analysis): Imaging, biomarker, and patient-data analytics.
- [AI/ML & Software Development](/services/ai-ml-development): Custom ML models and software for diagnostics and treatment planning.
- [In Vivo Experiments](/services/in-vivo-experiments): Preclinical experiments for therapy validation.
- [Smart Omics & Imaging Analytics](/services/smart-omics-imaging): Multi-omics integration with imaging analytics.
- [Digital Twins & Mathematical Modeling](/services/digital-twins): Patient- and disease-specific virtual models for precision oncology.
- [AI-Powered Metabolomics & Lipidomics](/services/metabolomics-analysis): LC-MS/MS and GC-MS metabolite identification, pathway analysis, biomarker discovery.
- [Products](/products): Prognostic, LabFlow, and other software products.
- [OncoPredict](/projects/oncopredict): Precision oncology research project.
- [Funding & Research](/funding-research): Grants, supporters, and research programs.
- [Company & Team](/company-team): About the team and leadership.
- [Patents & Licensing](/patents-licensing): IP portfolio and licensing.
- [About](/about): Mission and company background.
- [Consultation](/consultation): Schedule a consultation via Calendly.
- [Contact](/contact): Phone, email, and office addresses.